Mary Brindle

18 timestamped statements across 1 collection — auto-found in recorded discussions, each timestamp jumps to the exact moment.

Pectus Excavatum · guest expert

Featured diaries

▶ Ep 41 · 8:05
So, I mean, it's not, it's not just a one-time thing, and it also like it costs money. So that's the other thing where I think doing the study is important because right now, uh, a lot of insurance agencies will cover it, you know, in Canada, you do need to sort of uh advocate to the health systems to cover it. So having this data that shows its effectiveness, I think is actually, it's really useful to have.
quote · Pectus Excavatum
▶ Ep 41 · 8:05
So, I mean, it's not, it's not just a one-time thing, and it also like it costs money. So that's the other thing where I think doing the study is important because right now, uh, a lot of insurance agencies will cover it, you know, in Canada, you do need to sort of uh advocate to the health systems to cover it. So having this data that shows its effectiveness, I think is actually, it's really useful to have.
quote · Pectus Excavatum

Nothing matches these filters — clear the search or widen the filters.

Pectus Excavatum 18 entries

Journal of Pediatric Surgery Article Review: July 2023, PAPS Issue

▶ Ep 41 · 2:31
host_summary Cryoanalgesia was associated with a 70% decrease in complication rates, from approximately 33% down to 17%. ↗
▶ Ep 41 · 2:31
clinical Cryoanalgesia was associated with a 70% decrease in complication rates, from approximately 33% down to 17%. ↗
▶ Ep 41 · 3:48
host_summary The chest tube study included 130 lung resections performed between 2013 and 2022. ↗
▶ Ep 41 · 3:48
clinical The chest tube study included 130 lung resections performed between 2013 and 2022. ↗
▶ Ep 41 · 5:15
quote One thing that makes it a little bit tough is that balance between those patients who might need a chest tube if you don't put it in, that need for an intervention that you had to planned versus this much larger potential benefit, more patients uh impacted who might never need the chest tube at all. So how do you balance a patient who needs to go back emergently for a procedure? ↗
▶ Ep 41 · 5:15
quote One thing that makes it a little bit tough is that balance between those patients who might need a chest tube if you don't put it in, that need for an intervention that you had to planned versus this much larger potential benefit, more patients uh impacted who might never need the chest tube at all. So how do you balance a patient who needs to go back emergently for a procedure? ↗
▶ Ep 41 · 6:37
host_summary The pilonidal disease study included 198 patients presenting between 2019 and 2022, with data prospectively gathered in a retrospective study design. ↗
▶ Ep 41 · 6:37
clinical The pilonidal disease study included 198 patients presenting between 2019 and 2022, with data prospectively gathered in a retrospective study design. ↗
▶ Ep 41 · 8:05
quote So, I mean, it's not, it's not just a one-time thing, and it also like it costs money. So that's the other thing where I think doing the study is important because right now, uh, a lot of insurance agencies will cover it, you know, in Canada, you do need to sort of uh advocate to the health systems to cover it. So having this data that shows its effectiveness, I think is actually, it's really useful to have. ↗
▶ Ep 41 · 8:05
quote So, I mean, it's not, it's not just a one-time thing, and it also like it costs money. So that's the other thing where I think doing the study is important because right now, uh, a lot of insurance agencies will cover it, you know, in Canada, you do need to sort of uh advocate to the health systems to cover it. So having this data that shows its effectiveness, I think is actually, it's really useful to have. ↗
▶ Ep 41 · 8:12
opinion Insurance coverage for laser hair reduction varies, with some agencies covering it while in Canada advocacy to health systems is needed, making effectiveness data important for coverage decisions. ↗
▶ Ep 41 · 8:12
opinion Insurance coverage for laser hair reduction varies, with some agencies covering it while in Canada advocacy to health systems is needed, making effectiveness data important for coverage decisions. ↗
▶ Ep 41 · 8:55
clinical All three articles were chosen as PAPS Award winners at the annual conference. ↗
▶ Ep 41 · 8:55
clinical All three articles were chosen as PAPS Award winners at the annual conference. ↗
▶ Ep 41 · 8:55
quote They were all chosen as the Pabst Award winners at our annual conference. And I will also say that each one of them, I think is important in the evolution of pediatric surgery, not necessarily like the revolution of it, but I think they're all really important for how we manage sort of day to day. Pediatric surgical care. ↗
▶ Ep 41 · 8:55
quote They were all chosen as the Pabst Award winners at our annual conference. And I will also say that each one of them, I think is important in the evolution of pediatric surgery, not necessarily like the revolution of it, but I think they're all really important for how we manage sort of day to day. Pediatric surgical care. ↗
▶ Ep 41 · 9:01
opinion The three studies represent evolutionary (rather than revolutionary) advances important for day-to-day pediatric surgical care management. ↗
▶ Ep 41 · 9:01
opinion The three studies represent evolutionary (rather than revolutionary) advances important for day-to-day pediatric surgical care management. ↗